New Drug Approvals

Home » REVIEW » Dr. Jeffrey Kiplinger at Averica Discovery Services, Speeding Discovery into Development

Dr. Jeffrey Kiplinger at Averica Discovery Services, Speeding Discovery into Development



Read all about Organic Spectroscopy on ORGANIC SPECTROSCOPY INTERNATIONAL 


Blog Stats

  • 1,719,948 hits

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 2,029 other followers

add to any



Jeffrey Kiplinger

President & CEO at Averica Discovery Services

Speeding Discovery into Development


twitter: @averica_feed

From 2001 through 2007, Dr. Kiplinger consulted with a variety of discovery technology companies on the optimization of chemistry discovery process. Previously, he founded the Gilson Center for Integrated Discovery Technology (CIDT) as a partnership development center responsible for high-speed chemistry and analysis products.

From 1988 to 1998 at Pfizer, Dr. Kiplinger supported discovery chemistry activities by developing new applications for mass spectrometry and chromatography, in particular Open Access HPLC/MS and mass spectrometry-directed preparative chromatography.

Twenty-five years in scientific leadership positions with both small and large companies with an expertise in mass spectrometry and chromatography supporting Drug Discovery. Consulted extensively with emerging companies, expanding operations, academic incubators and research parks.

Founded three companies since 1998, including Averica Discovery Services (Worcester MA), a contract research firm for pharmaceutical discovery clients. Currently President and CEO of Averica.

Specialties:Analytical chemistry, analytical instrumentation, pharmaceutical discovery and development support, operations, strategic planning, contract management.


President & CEOAverica Discovery Services

March 2007 – Present (8 years 7 months)

CRO to pharmaceutical discovery organizations. Provides specialty purification and characterization support, including chiral compound purification, for drug discovery projects.

Averica has built a proven track record in providing clients with a critical compound supply, both quickly and efficiently. In fact, we have a greater than 95% success rate with chiral separations and other challenging separations.

Principal and FounderPragmatic Approach LLC

January 1998 – July 2007 (9 years 7 months)

Consultancy to small and mid-sized biopharmaceutical companies offering analytical chemistry support of drug discoveyr and development, as well as strategic input to expanding organizations.

Executive DirectorGilson Inc.

December 1998 – January 2001 (2 years 2 months)

Created and managed Gilson’s Center for Integrated Discovery Technology, CIDT; an applications and technology development center. Developed concept, designed and established new facility and business arm, hired staff, managed partnerships.

Senior Research InvestigatorPfizer Inc.

December 1988 – December 1998 (10 years 1 month)

Managed drug discovery support for chemistry research organization at Groton CT research headquarters. Developed new technologies for rapid analytical support and enablement of high speed discovery work.

Jeff Kiplinger


Indiana UniversityPhD, Organic and Analytical Chemistry

June 1980 – August 1984

Butler UniversityB.S., Chemistry, Physics

September 1976 – May 1980

Activities and Societies: Lambda Chi Alpha fraternity, Chemistry Department



Jeffrey P. Kiplinger, PhD

President, Averica Discovery Services

260 Cedar Hill Street

Marlborough, MA 01752

(direct)    1-508-757-4600 x 300

(mobile)  1-781-366-1995

twitter: @averica_feed

260 Cedar Hill St, Marlborough, MA 01752, USA

Map of 260 Cedar Hill St 260 Cedar Hill St, Marlborough, MA 01752, USA

5 Keys to Fast Impurity Isolation – Averica

5 Keys to Fast Impurity Isolation


//////Jeffrey Kiplinger, averica, 260 Cedar Hill St, Marlborough, MA 01752, USA


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


Follow New Drug Approvals on

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 2,029 other followers



DR ANTHONY MELVIN CRASTO, Born in Mumbai in 1964 and graduated from Mumbai University, Completed his Ph.D from ICT, 1991,Matunga, Mumbai, India, in Organic Chemistry, The thesis topic was Synthesis of Novel Pyrethroid Analogues, Currently he is working with GLENMARK PHARMACEUTICALS LTD, Research Centre as Principal Scientist, Process Research (bulk actives) at Mahape, Navi Mumbai, India. Total Industry exp 29 plus yrs, Prior to joining Glenmark, he has worked with major multinationals like Hoechst Marion Roussel, now Sanofi, Searle India Ltd, now RPG lifesciences, etc. He has worked with notable scientists like Dr K Nagarajan, Dr Ralph Stapel, Prof S Seshadri etc, He did custom synthesis for major multinationals in his career like BASF, Novartis, Sanofi, etc., He has worked in Discovery, Natural products, Bulk drugs, Generics, Intermediates, Fine chemicals, Neutraceuticals, GMP, Scaleups, etc, he is now helping millions, has 9 million plus hits on Google on all Organic chemistry websites. His friends call him worlddrugtracker. His New Drug Approvals, Green Chemistry International, All about drugs, Eurekamoments, Organic spectroscopy international, etc in organic chemistry are some most read blogs He has hands on experience in initiation and developing novel routes for drug molecules and implementation them on commercial scale over a 29 year tenure till date Aug 2016, Around 30 plus products in his career. He has good knowledge of IPM, GMP, Regulatory aspects, he has several International patents published worldwide . He has good proficiency in Technology transfer, Spectroscopy, Stereochemistry, Synthesis, Polymorphism etc., He suffered a paralytic stroke/ Acute Transverse mylitis in Dec 2007 and is 90 %Paralysed, He is bound to a wheelchair, this seems to have injected feul in him to help chemists all around the world, he is more active than before and is pushing boundaries, He has 9 million plus hits on Google, 2.5 lakh plus connections on all networking sites, 25 Lakh plus views on dozen plus blogs, He makes himself available to all, contact him on +91 9323115463, email, Twitter, @amcrasto , He lives and will die for his family, 90% paralysis cannot kill his soul., Notably he has 13 lakh plus views on New Drug Approvals Blog in 212 countries...... , He appreciates the help he gets from one and all, Friends, Family, Glenmark, Readers, Wellwishers, Doctors, Drug authorities, His Contacts, Physiotherapist, etc

Personal Links

View Full Profile →



Follow my blog with Bloglovin The title of your home page You could put your verification ID in a comment Or, in its own meta tag Or, as one of your keywords Your content is here. The verification ID will NOT be detected if you put it here.
%d bloggers like this: